Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 37Other hematologic neoplasm 26Myeloid 17Plasma cell 12Classical hematology 6Genitourinary 4CNS 4Dermatologic 3Sarcoma 2Gynecologic 2Breast 2Gastrointestinal 1

Conditions

Wilms Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Neuroblastoma 1Neoplasms, Germ Cell and Embryonal 1Melanoma 1Lymphoma 1Digestive System Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Adenocarcinoma, Clear Cell 1

Interventions

pembrolizumab 6Nivolumab 5Magnetic Resonance Spectroscopy 4fludarabine 3Sirolimus 3Radiotherapy 3Methods 3Gemcitabine 3Early Intervention, Educational 3Drug Therapy 3Biopsy 3spartalizumab 2epacadostat 2atezolizumab 2X-Rays 2Topotecan 2Surveys and Questionnaires 2Specimen Handling 2Palliative Care 2Nuclear Medicine Department, Hospital 2Ipilimumab 2Interleukin-2 2Educational Status 2Dasatinib 2Cyclophosphamide 2Carboplatin 2vocimagene amiretrorepvec 1ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma × Alemtuzumab × Gastrointestinal × Clear all
NCT01625351 2026-02-06

A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

St. Jude Children's Research Hospital

Phase 1 Completed
23 enrolled
CNSDermatologicGastrointestinalGenitourinaryLymphoidSarcoma

Carcinoma, Renal Cell, Digestive System Neoplasms, Carcinoma, Hepatocellular, Lymphoma, Melanoma, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Adenocarcinoma, Clear Cell, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡